JP2024516110A5 - - Google Patents
Info
- Publication number
- JP2024516110A5 JP2024516110A5 JP2023562191A JP2023562191A JP2024516110A5 JP 2024516110 A5 JP2024516110 A5 JP 2024516110A5 JP 2023562191 A JP2023562191 A JP 2023562191A JP 2023562191 A JP2023562191 A JP 2023562191A JP 2024516110 A5 JP2024516110 A5 JP 2024516110A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- weight
- optionally
- bacteria
- pharmaceutical product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163172370P | 2021-04-08 | 2021-04-08 | |
| US63/172,370 | 2021-04-08 | ||
| US202163197000P | 2021-06-04 | 2021-06-04 | |
| US63/197,000 | 2021-06-04 | ||
| PCT/US2022/023979 WO2022217030A1 (en) | 2021-04-08 | 2022-04-08 | Pharmaceutical composition containing bacteria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516110A JP2024516110A (ja) | 2024-04-12 |
| JP2024516110A5 true JP2024516110A5 (https=) | 2025-04-15 |
Family
ID=81581166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023562191A Pending JP2024516110A (ja) | 2021-04-08 | 2022-04-08 | 細菌を含有する医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250073285A1 (https=) |
| EP (1) | EP4319723A1 (https=) |
| JP (1) | JP2024516110A (https=) |
| KR (1) | KR20240006543A (https=) |
| TW (1) | TW202304415A (https=) |
| WO (1) | WO2022217030A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112805367B (zh) * | 2018-06-07 | 2024-08-09 | 阿尔图根治疗有限公司 | 用于治疗艰难梭菌的方法和组合物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4775536A (en) | 1986-02-24 | 1988-10-04 | Bristol-Myers Company | Enteric coated tablet and process for making |
| US5292522A (en) | 1989-06-20 | 1994-03-08 | Rohm Gmbh | Aqueous film coating agent for solid medicaments |
| US5047258A (en) | 1989-07-14 | 1991-09-10 | Sterling Drug Inc. | Aqueous spray-coating process |
| US6623759B2 (en) | 1996-06-28 | 2003-09-23 | Astrazeneca Ab | Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof |
| DE19631084A1 (de) | 1996-08-01 | 1998-02-05 | Basf Ag | Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut |
| US6312728B1 (en) | 1998-07-07 | 2001-11-06 | Cascade Development, Inc. | Sustained release pharmaceutical preparation |
| DE69924735T2 (de) | 1998-07-28 | 2006-01-19 | Tanabe Seiyaku Co., Ltd. | Zur wirkstoffabgabe an zielorten im darm fähige zubereitung |
| US20040028737A1 (en) | 2002-08-12 | 2004-02-12 | Kopran Research Laboratories Limited | Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same |
| DE10260919A1 (de) | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
| EP1677770A2 (en) | 2003-10-31 | 2006-07-12 | Dexcel Ltd. | Stable lansoprazole formulation |
| US9149439B2 (en) | 2005-03-21 | 2015-10-06 | Sandoz Ag | Multi-particulate, modified-release composition |
| DE102005032806A1 (de) | 2005-07-12 | 2007-01-18 | Röhm Gmbh | Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten |
| CA2760248C (en) * | 2009-04-30 | 2019-05-28 | Actogenix Nv | Cryoprotectants for freeze drying of lactic acid bacteria |
| MX357575B (es) | 2013-03-01 | 2018-07-16 | Bpsi Holdings Llc | Recubrimientos de pelicula de liberacion retardada que contienen silicato de calcio y sustratos recubiertos con los mismos. |
| SMT202000555T1 (it) | 2017-06-14 | 2020-11-10 | 4D Pharma Res Limited | Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi |
| TW201906620A (zh) * | 2017-07-05 | 2019-02-16 | 美商艾弗洛生物科技股份有限公司 | 使用動物雙岐桿菌乳亞種 (bifidobacterium animalis ssp. lactis) 治療癌症之組合物及方法 |
| GB2564481B (en) * | 2017-07-14 | 2019-10-23 | 4D Pharma Leon S L U | Process |
| JP7402805B2 (ja) * | 2018-02-06 | 2023-12-21 | エヴェロ バイオサイエンシズ，インコーポレーテッド | ベイロネラ（Ｖｅｉｌｌｏｎｅｌｌａ）の細菌を使用して癌及び免疫障害を処置するための組成物及び方法 |
| CN112088211A (zh) * | 2018-05-31 | 2020-12-15 | 株式会社好固工 | 乳酸菌及其用途 |
| CN112805367B (zh) | 2018-06-07 | 2024-08-09 | 阿尔图根治疗有限公司 | 用于治疗艰难梭菌的方法和组合物 |
| TW202038979A (zh) | 2018-12-12 | 2020-11-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組成物 |
| IT201900006056A1 (it) * | 2019-04-18 | 2020-10-18 | Probiotical Spa | Procedimento per la preparazione di una biomassa di cellule di batteri liofilizzate stabili e determinazione della loro stabilità mediante un metodo citofluorimetrico |
| CN114245742A (zh) * | 2019-06-21 | 2022-03-25 | 伊夫罗生物科学公司 | 使用普雷沃菌属治疗th2介导的病症的组合物和方法 |
| CN110251474B (zh) * | 2019-07-15 | 2022-01-07 | 北京工商大学 | 一种淀粉基大肠靶向双层益生菌片的制备方法 |
| WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
-
2022
- 2022-04-08 TW TW111113512A patent/TW202304415A/zh unknown
- 2022-04-08 EP EP22721538.1A patent/EP4319723A1/en not_active Withdrawn
- 2022-04-08 WO PCT/US2022/023979 patent/WO2022217030A1/en not_active Ceased
- 2022-04-08 US US18/285,890 patent/US20250073285A1/en active Pending
- 2022-04-08 JP JP2023562191A patent/JP2024516110A/ja active Pending
- 2022-04-08 KR KR1020237038507A patent/KR20240006543A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510158A5 (https=) | ||
| US20150050245A1 (en) | Methods and delivery system for beneficial additive and subtractive biological agents to promote balanced mammalian gastrointestinal flora | |
| JP2002505251A (ja) | 乳酸菌の安定化のための微細腸溶性コーティング顆粒 | |
| TWI584824B (zh) | A capsule for delivery to a large intestine and a method of manufacturing the same | |
| US20060127489A1 (en) | Targeted delivery | |
| JP2018518478A (ja) | エタノールの影響に対する耐性を有する医薬品組成物または栄養機能食品組成物 | |
| US10016467B2 (en) | Formulations of viable cells for oral delivery | |
| KR101686176B1 (ko) | 내산성 및 안정성이 향상된 프로바이오틱스 코팅 고체 조성물의 제조 방법 | |
| Muvva et al. | Modified pectins for colon-specific drug delivery | |
| EP3646857A1 (en) | Colonic delivery system for microorganisms | |
| JP2024516110A5 (https=) | ||
| RU2008120672A (ru) | Композиции для перорального введения, содержащие тайгециклин | |
| Brachkova et al. | Evaluation of the viability of Lactobacillus spp. after the production of different solid dosage forms | |
| JP5957280B2 (ja) | 大腸デリバリーシームレスカプセル製剤及びその製造方法 | |
| JP5940869B2 (ja) | 腸内環境改善有核錠製剤及びハードカプセル製剤 | |
| CN218165648U (zh) | 一种保持益生菌活性的制剂 | |
| WO2021152869A1 (ja) | 腸溶性組成物、該腸溶性組成物を含む飲食品、該腸溶性組成物の崩壊時間を制御する方法、及び該腸溶性組成物の製造方法 | |
| JPH11139978A (ja) | 腸溶性生菌製剤 | |
| Lalani et al. | Applications of polymers in small intestinal drug delivery | |
| GB2394416A (en) | Targeted delivery of microbially encapsulated drugs | |
| KR20250004712A (ko) | 하나 이상의 방출 촉진제를 포함하는 이중 코팅 시스템을 사용한 pH 3 내지 6 에서 약물 방출을 갖는 투여 형태 | |
| JPWO2014097664A1 (ja) | 大腸送達カプセル及びその製造方法 | |
| de Conto et al. | Polysaccharides used for Microencapsulation Processes | |
| US20240189236A1 (en) | Composition comprising a (meth)acrylate copolymer, an alkali or ammonium salt of a saturated aliphatic monocarboxylic acid and specific glidants | |
| EP4366708A1 (en) | Hard shell capsules having improved colon release |